about
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).
Read More
11.35
1.33
(13.27%)
56,491
XNAS Volume
XNAS 02 Apr, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for LeonaBio Inc is scheduled for today, for the purpose of LeonaBio Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
LeonaBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..